Despite Defective Mouse Arrays, Users Remain Largely Loyal to Affy | GenomeWeb

NEW YORK, March 9 – A Japanese tumorogenesis researcher arrived in New York on Wednesday to begin a mouse microarray project at Memorial Sloan-Kettering's Ludwig Center for Cancer Research only to find out that defects in the Affymetrix U74 mouse microarrays had stopped the project dead in its tracks. 

“That whole plan has been six months in the making,” said Michael Marino, a researcher at the Ludwig Institute. “Today we find we can’t go ahead with the research – it’s just wasting time.”

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.